Peripheral blood miR-328 expression as a potential biomarker for the early diagnosis of NSCLC

International Journal of Molecular Sciences

Volumn 14, Issue 5, 2013, Pages 10332-10342

  Ulivi, Paola ^a   Foschi, Giovanni ^a   Mengozzi, Marta ^b   Scarpi, Emanuela ^a   Silvestrini, Rosella ^a   Amadori, Dino ^a   Zoli, Wainer ^a  

^a DEPARTMENT OF MEDICAL ONCOLOGY   (Italy)

^b MORGAGNI PIERANTONI HOSPITAL   (Italy)

Author keywords

Diagnosis; miRNAs; Non small cell lung cancer; Serum

Indexed keywords

MICRORNA; MICRORNA 140; MICRORNA 18A; MICRORNA 328; MICRORNA 339; MICRORNA 361; MICRORNA 423; RNA; UNCLASSIFIED DRUG; MIRN328 MICRORNA, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE MARKER; EARLY DIAGNOSIS; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCATION; HOUSEKEEPING GENE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; BLOOD; CARCINOMA, NON-SMALL-CELL LUNG; GENE EXPRESSION REGULATION; GENETICS; LUNG NEOPLASMS; MIDDLE AGED; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; EARLY DETECTION OF CANCER; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

EID: 84878233310     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms140510332     Document Type: Article

References (31)

1. National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl. J. Med. 2011, 365, 395-409.
2. Berrington de González, A.; Kim, K.P.; Berg, CD. Low-dose lung computed tomography screening before age 55: Estimates of the mortality reduction required to outweigh the radiation-induced cancer risk. J. Med. Screen. 2008, 15, 153-158.
3. Swensen, S.J.; Jett, J.R.; Hartman, T.E.; Midthun, D.E.; Mandrekar, S.J.; Shauna, L.; Hillman, S.L.; Sykes, A.M.; Aughenbaugh, G.L.; Bungum, A.O.; et al. CT screening for lung cancer: Five-year prospective experience. Radiology 2005, 235, 259-265.
4. Calin, G.A.; Croce, CM. MicroRNA signatures in human cancers. Nat. Rev. Cancer 2006, 6, 857-866.
5. Esquela-Kerscher, A.; Slack, F.J. Oncomirs-"microRNAs with a role in cancer". Nat. Rev. Cancer 2006, 6, 259-269.
6. Sassen, S.; Miska, E.A.; Caldas, C. MicroRNA: Implications for cancer. Virchows Arch. 2008, 452, 1-10.
7. Zhang, B.; Pan, X.; Cobb, G.P.; Anderson, T.A. MicroRNAs as oncogenes and tumor suppressors. Dev. Biol. 2007, 302, 1-12.
8. Chen, X.; Ba, Y.; Ma, L.; Cai, X.; Yin, Y.; Wang, K.; Guo, J.; Zhang, Y.; Chen, J.; Guo, X.; et al. Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008, 18, 997-1006.
9. Gilad, S.; Meiri, E.; Yogev, Y.; Benjamin, S.; Lebanony, D.; Yerushalmi, N.; Benjamin, H.; Kushnir, M.; Cholakh, H.; Melamed, N.; et al. Serum microRNAs are promising novel biomarkers. PLoS One 2008, 3, e3148.
10. Mitchell, P.S.; Parkin, R.K.; Kroh, E.M.; Fritz, B.R.; Wyman, S.K.; Pogosova-Agadjanyan, E.L.; Peterson, A.; Noteboom, J.; O'Briant, K.C.; Allen, A.; et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. USA 2008, 105, 10513-10518.
11. Keller, A.; Leidinger, P.; Borries, A.; Wendschlag, A.; Wucherpfennig, F.; Scheffler, M.; Huwer, H.; Lenhof, H.P.; Meese, E. miRNAs in lung cancer-Studying complex fingerprints in patient's blood cells by microarray experiments. BMC Cancer 2009, 9, e353.
12. Häusler, S.F.; Keller, A.; Chandran, P.A.; Ziegler, K.; Zipp, K.; Heuer, S.; Krockenberger, M.; Engel, J.B.; Hönig, A.; Scheffler, M.; et al. Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening. Br. J. Cancer 2010, 103, 693-700.
13. Jeong, H.C.; Kim, E.K.; Lee, J.H.; Lee, J.M.; Yoo, H.N.; Kim, J.K. Aberrant expression of let-7a miRNA in the blood of non-small cell lung cancer patients. Mol. Med. Rep. 2011, 4, 383-387.
14. Weber, D.G; Johnen, G; Bryk, O.; Jöckel, K.H.; Brüning, T. Identification of miRNA-103 in the cellular fraction of human peripheral blood as a potential biomarker for malignant mesothelioma-A pilot study. PLoS One 2012, 7, e30221.
15. Patnaik, S.K.; Yendamuri, S.; Kannisto, E.; Kucharczuk, J.C.; Singhal, S.; Vachani, A. MicroRNA expression profiles of whole blood in lung adenocarcinoma. PLoS One 2012, 7, e46045.
16. Leidinger, P.; Keller, A.; Borries, A.; Huwer, H.; Rohling, M.; Huebers, J.; Lenhof, H.P.; Meese, E. Specific peripheral miRNA profiles for distinguishing lung cancer from COPD. Lung Cancer 2011, 74, 41-47.
17. Sanfiorenzo, C; Ilie, MI; Belaid, A.; Barlési, F.; Mouroux, J.; Marquette, C.H.; Brest, P.; Hofman, P. Two panels of plasma microRNAs as non-invasive biomarkers for prediction of recurrence in resectable NSCLC. PLoS One 2013, 8, e54596.
18. Hennessey, P.T.; Sanford, T.; Choudhary, A.; Mydlarz, W.W.; Brown, D.; Adai, A.T.; Ochs, M.F.; Ahrendt, S.A.; Mambo, M.; Califano J. A. Serum microRNA biomarkers for detection of non-small cell lung cancer. PLoS One 2012, 7, e32307.
19. Cho, W.C. Promises and challenges in developing miRNA as a molecular diagnostic tool for lung cancer. Expert Rev. Mol. Diagn. 2011, 11, 763-766.
20. Lin, P.Y.; Yang, P.C. Circulating miRNA signature for early diagnosis of lung cancer. EMBO Mol. Med. 2011, 3, 436-437.
21. Shen, J.; Todd, N.W.; Zhang, H.; Yu, L.; Lingxiao, X.; Mei, Y.; Guarnera, M.; Liao, J.; Chou, A.; Lu, C.L.; et al. Plasma microRNAs as potential biomarkers for non-small-cell lung cancer. Lab. Invest. 2011, 91, 579-587.
22. Roth, C.; Stückrath, I.; Pantel, K.; Izbicki, J.R.; Tachezy, M.; Schwarzenbach, H. Low levels of cell-free circulating miR-361-3p and miR-625* as blood-based markers for discriminating malignant from benign lung tumors. PLoS One 2012, 7, e38248.
23. Zhu, W.; Liu, X.; He, J.; Chen, D.; Hunag, Y.; Zhang, Y.K. Overexpression of members of the microRNA-183 family is a risk factor for lung cancer: A case control study. BMC Cancer 2011, 11, e393
24. Showe, M.K.; Vachani, A.; Kossenkov, A.V.; Yousef, M.; Nichols, C.; Nikonova, E.V.; Chang, C.; Kucharczuk, J.; Tran, B.; Wakeam, E.; et al. Gene expression profiles in peripheral blood mononuclear cells can distinguish patients with non-small cell lung cancer from patients with nonmalignant lung disease. Cancer Res. 2009, 69, 9202-9210.
25. Zheng, D.; Haddadin, S.; Wang, Y.; Gu, L.-Q.; Perry, M.C.; Freter, C.E.; Wang, M.X. Plasma microRNAs as novel biomarkers for early detection of lung cancer. Int. J. Clin. Exp. Pathol. 2011, 4, 575-586.
26. Arora, S.; Ranade, A.R.; Tran, N.L.; Nasser, S.; Sridhar, S.; Korn, R.L.; Ross, J.T.; Dhruv, H.; Foss, K.M.; Sibenaller, Z.; et al. MicroRNA-328 is associated with (non-small) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migration. Int. J. Cancer 2011, 129, 2621-2631.
27. Hui, A.B.; Lenarduzzi, M.; Krushel, T.; Waldron, L.; Pintilie, M.; Shi, W.; Perez-Ordonez, B.; Jurisica, I.; O'Sullivan, B.; Waldron, J.; et al. Comprehensive microRNA profiling for head and neck squamous cell carcinomas. Clin. Cancer Res. 2010, 16, 1129-1139.
28. Lin, J.; Huang, S.; Wu, S.; Ding, J.; Zhao, Y.; Liang, L.; Tian, Q.; Zha, R.; Zhan, R.; He, X. MicroRNA-423 promotes cell growth and regulates G1/S transition by targeting p21Cip1/Waf1 in hepatocellular carcinoma. Carcinogenesis 2011, 32, 1641-1647.
29. Kudo, Y.; Takata, T.; Ogawa, I.; Sato, S.; Nikai, H. Expression of p53 and p21Cip1/Waf1 proteins in oral epithelial dysplasias and squamous cell carcinomas. Oncol. Rep. 1999, 6, 539-545.
30. Vandesompele, J.; de Preter, K.; Pattyn, F.; Poppe, B.; van Roy, N.; de Paepe, A.; Speleman, F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 18, doi:10.1186/gb-2002-3-7-research0034.
31. Armitage, P.; Berry, G. Statistical Methods in Medical Research, 2nd ed.; Blackwell Scientific Publications: Boston, MA, USA, 1987; pp. 387-393.